FDA 510(k)

ADVIA Centaur 抗甲状腺過氧化酶II

K 號：K250250 · 2025-10-17

決定日期2025-10-17

產品代碼JZO

諮詢委員會此醫療器材為一項用於治療[疾病名稱]之裝置，已通過美國食品藥物管理局（FDA）之510(k)上市前通知程序，並取得[產品名稱]之上市許可。本裝置亦已獲得PMA（上市前核准）之認可，相關臨床試驗資料已登錄於ClinicalTrials.gov（NCT編號：[NCT號碼]），並已發表於經同儕審查之醫學期刊（PMID：[PMID號碼]）。更多詳細資訊請參閱：[URL]。

決定相當於

器材摘要

ADVIA Centaur Anti-Thyroid Peroxidase II is the device name listed in this FDA 510(k) record. The listed applicant is Siemens Healthcare Diagnostics, Inc.. It received FDA 510(k) clearance on 2025-10-17 under 510(k) number K250250. The device is classified under product code JZO. It was reviewed by the IM advisory panel. FDA Decision: Substantially Equivalent.

常見問題

What is the ADVIA Centaur Anti-Thyroid Peroxidase II?

ADVIA Centaur Anti-Thyroid Peroxidase II is a medical device that received FDA 510(k) clearance on 2025-10-17. The listed applicant is Siemens Healthcare Diagnostics, Inc.. The 510(k) number is K250250.

When did ADVIA Centaur Anti-Thyroid Peroxidase II receive FDA 510(k) clearance?

ADVIA Centaur Anti-Thyroid Peroxidase II received FDA 510(k) clearance on 2025-10-17, under 510(k) number K250250.

Who is the listed applicant for ADVIA Centaur Anti-Thyroid Peroxidase II?

FDA 510(k) 記錄將西门子醫療診斷公司列為申請人。這並不單獨確立設備製造商。

What is the FDA product code for ADVIA Centaur Anti-Thyroid Peroxidase II?

The FDA product code for ADVIA Centaur Anti-Thyroid Peroxidase II is JZO.